- Business Wire•4 days ago
ArQule, Inc. today announced it will report financial results for the third quarter 2016 before the market opens on Monday, November 7, 2016. The Company will hold a conference call and webcast on the same day at 9:00 a.m.
- Business Wire•last monthArQule to Present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28, 2016
ArQule, Inc. today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will present at The Leerink Partners Rare Disease and Immuno-Oncology Roundtable on September 28th, 2016, at 4:10 p.m.
ArQule Inc. (ARQL)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
|Day's Range||1.38 - 1.49|
|52wk Range||1.37 - 2.65|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-6.05|
|Avg Vol (3m)||80,286|
|Dividend & Yield||N/A (N/A)|